Invention Grant
US07972597B2 Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteins
有权
使用针对单核细胞趋化蛋白的抗体降低趋化性的方法
- Patent Title: Methods of reducing chemotaxis using antibodies against monocyte chemotactic proteins
- Patent Title (中): 使用针对单核细胞趋化蛋白的抗体降低趋化性的方法
-
Application No.: US12612087Application Date: 2009-11-04
-
Publication No.: US07972597B2Publication Date: 2011-07-05
- Inventor: Antonin R. De Fougerolles , Victor E. Kotelianski , Carl Reid , Ellen Garber
- Applicant: Antonin R. De Fougerolles , Victor E. Kotelianski , Carl Reid , Ellen Garber
- Applicant Address: US MA Cambridge
- Assignee: Biogen Idec MA, Inc.
- Current Assignee: Biogen Idec MA, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K39/395
- IPC: A61K39/395
Abstract:
The invention provides antibodies that bind to a plurality of β-chemokines, particularly monocyte chemotactic proteins MCP-1, MCP-2 and MCP-3. The invention also provides cells producing the antibodies, and methods of making and using the same.
Public/Granted literature
- US20100166757A1 ANTIBODIES AGAINST MONOCYTE CHEMOTACTIC PROTEINS Public/Granted day:2010-07-01
Information query
